This site is intended for healthcare professionals

uniQure announces positive top-line data from the HOPE-B pivotal trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B.

Read time: 2 mins
Last updated:26th Nov 2020
Published:26th Nov 2020
Condition: Haemophilia B
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest